Stockholm - Delayed Quote • SEK Egetis Therapeutics AB (publ) (EGTX.ST) Follow Compare 6.59 +0.15 (+2.33%) At close: December 20 at 5:29:32 PM GMT+1 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Exploring Three Swedish Exchange Growth Companies With High Insider Ownership As global markets navigate through mixed economic signals, Sweden's market remains a focal point for investors looking for growth opportunities. This context sets the stage to explore three Swedish growth companies with high insider ownership, which often indicates confidence from those closest to the company's operations and future prospects. Swedish Growth Leaders With High Insider Stakes June 2024 As global markets experience mixed signals with regions showing varied economic data, Sweden's market remains a point of interest for investors looking for growth opportunities. In this environment, companies with high insider ownership can be particularly appealing, as they often signal strong confidence from those closest to the business in its growth prospects and governance. Performance Overview Trailing total returns as of 12/20/2024, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index Return EGTX.ST OMX Stockholm 30 Index YTD +18.10% +3.19% 1-Year +8.93% +3.78% 3-Year +3.94% +7.32%